BD Boston
Date: Location: Cost:
Mar 25 - 26, 2014 Four Seasons Hotel
200 Boylston Street
Boston, MA 02116
(617) 338-4400

Starting at $1975

 

Dress Code:
Business Attire

Register

March 25, 2014

Time Agenda
8:00-9:00 am

Registration and Networking Breakfast

9:00-10:00 am

Welcome and Opening Remarks
Co-hosts: PJ Anand, Brian Concannon, Michelle Dipp, Ashley Dombkowski, Iain Dukes, Chris Garabedian, Barry Greene, JC Gutierrez-Ramos, Tim Harris, Mary Lynne Hedley, John Maraganore, Mark Miller, Dan Paterson, Laurence Reid, Jason Rhodes, Rick Shea, Christoph Westphal

10:00-10:30 am

2014 Market Outlook: Drugs, Devices and Diagnostics
Art Krieg, Sarepta Therapeutics; Dirk Kuyper, IlluminOss; Dan Paterson, Verastem; Peter Thompson, OrbiMed
Moderator: Harry Glorikian, Precision for Medicine

10:30-11:00 am

From Start-up to Public and Selling Product
Mark Corrigan, Zalicus; Ana Maiques, Neuroelectrics; Brian Sullivan, Verastem; Mark Twyman, GI Dynamics
Moderator: Mary Lynne Hedley, TESARO

11:00-11:30 am

New Models for Innovation
Belen Carrillo-Rivas, Pfizer; Susan Herbert, Merck; Iya Khalil, GNS Healthcare; John McDonough, T2 Biosystems; Barry Springer, Janssen
Moderator: David Lucchino, Semprus Biosciences

11:30-12:30 pm

Networking Lunch
Co-hosts: PJ Anand, Brian Concannon, Michelle Dipp, Ashley Dombkowski, Iain Dukes, Chris Garabedian, Barry Greene, JC Gutierrez-Ramos, Tim Harris, Mary Lynne Hedley, John Maraganore, Mark Miller, Dan Paterson, Laurence Reid, Jason Rhodes, Rick Shea, Christoph Westphal

12:30-12:50 pm

Moderated Keynote
Jim Clemmer, Covidien
Moderator: Dave Sabow, Silicon Valley Bank

12:50-1:20 pm

Optionality in Deal-making
Leland Gershell, Tonix Pharma; Brett Kaplan, Evercore; Dan Koerwer, BIND Therapeutics; Ivana Magovcevic-Liebisch, Teva
Moderator: Carl Gordon, OrbiMed

1:20-1:40 pm

Moderated Keynote: Scaling a Business
Brian Concannon, Haemonetics
Moderator: Chris Otey, Alexandria Venture Investments

1:40-2:10 pm

Pricing and Reimbursement Pressures
John Bridwell
, Vecna; John Brooks, Joslin Diabetes Center; Sam Rasty, Shire; Peter Thompson, OrbiMed
Moderator: Dan Grau, Heptares Therapeutics

2:10-2:40 pm

What's New in Devices
PJ Anand, Alcyone Lifesciences; Luca Benatti, EryDel SpA; John McDonough, T2 Biosystems; Nirav Sheth, MC10
Moderator: Megan Gates, Mintz Levin

2:40-3:00 pm

Moderated Keynote
Frank Laukien
, Bruker
Moderator: Christoph Westphal, Verastem

3:00-3:30 pm

Networking Break

3:30-4:00 pm

Where Are Tomorrow's Drugs Coming From?
Rick Lundberg, Calorics Pharmaceuticals; John Mendlein, aTyr Pharma; Larry Miller, Macrolide Pharmaceuticals; Elias Papatheodorou, Covagen; Robert Urban, Johnson & Johnson
Moderator: Jonathan Kfoury, L.E.K.

4:00-4:30 pm

M&A Activity in 2014: Who Benefits Most, Pharma or Biotech?
Iain Dukes, Merck; Jeff Goater, Voyager Therapeutics; William Ho, New Leaf Venture Partners; John McDonald, Biogen Idec; Jason Rhodes, Epizyme
Moderator: Jeremy Goldberg, Torreya Partners

4:30-5:00 pm

Putting Patients at the Center
Stephen Beckman
, Pharmaxis; David-Alexandre Gros, Sanofi; Claudia Hirawat, PTC Therapeutics; Jeff Poulton, Shire; Dan Regan, Intercept Pharmaceuticals
Moderator: Penny Bemus, Dohmen Life Science Services

5:00-6:00 pm

Cocktails and Hors d’oeuvres

March 26, 2014

Time Agenda
7:15-8:00 am

Registration & Networking Breakfast

8:00-8:30 am

Welcome and Opening Remarks
Co-hosts: PJ Anand, Brian Concannon, Michelle Dipp, Ashley Dombkowski, Iain Dukes, Chris Garabedian, Barry Greene, JC Gutierrez-Ramos, Tim Harris, Mary Lynne Hedley, John Maraganore, Mark Miller, Dan Paterson, Laurence Reid, Jason Rhodes, Rick Shea, Christoph Westphal

8:30-9:00 am

Mid-size Biotech: Managing Shareholder Expectations While Focusing on Growth
Florian Kemmerich, Olympus Biotech; John Maraganore, Alnylam; Rick Shea, Momenta
Moderator: Lonnie Moulder, TESARO

9:00-9:30 am

Small Biotech: How to Partner Smartly
Carolyn Green, Atreaon; Duncan Higgons, Agios; Jigar Raythatha, Jounce Therapeutics; Michael Rivard, Avaxia Biologics
Moderator: Michelle Dipp, OvaScience

9:30-10:00 am

Incorporating Personalized Medicine Into your Pipeline: What are the Options?
Byron Hewett, SomaLogic; Steve Potts, Flagship Biosciences; Jennifer Wheler, MD Anderson Cancer Center
Moderator: Chris Garabedian, Sarepta Therapeutics

10:00-10:40 am

Networking Break

10:40-11:00 am

Moderated Keynote
Charlie Baker, 2014 Massachusetts Gubernatorial Candidate
Moderator: Christoph Westphal, Verastem

11:00-11:30 am

The Alnylam-Genzyme Deal
Laurence Reid, Alnylam; Andre Turenne, Genzyme/Sanofi
Moderator: Kingsley Taft, Goodwin Procter LLP

11:30-12:00 pm

2015 VC Outlook
Rich Aldrich
, Longwood Fund; Ashley Dombkowski, Bay City Capital; Jason Hafler, Sanofi-Genzyme BioVentures; Stephen Hoffman, PDL BioPharma; Antoine Papiernik, Sofinnova
Moderator: Michael Hanewich, Silicon Valley Bank

12:00-1:00 pm

Networking Lunch
Co-hosts: PJ Anand, Brian Concannon, Michelle Dipp, Ashley Dombkowski, Iain Dukes, Chris Garabedian, Barry Greene, JC Gutierrez-Ramos, Tim Harris, Mary Lynne Hedley, John Maraganore, Mark Miller, Dan Paterson, Laurence Reid, Jason Rhodes, Rick Shea, Christoph Westphal

1:00-1:30 pm

Pharma R&D: How are Pipelines Getting Filled?
Philippe Lopes-Fernandes, EMD Serono; Mark Miller, Eli Lilly; Christopher Seaton, Bayer; Bob Silverman, Roche; Frank Stonebanks, Triphase Accelerator
Moderator: Tim Harris, Biogen Idec

1:30-2:00 pm

Commercialization: How to Get it Right
Kurt Graves, Intarcia; Thomas McCourt, Ironwood Pharmaceuticals; Lita Nelsen, M.I.T.; David Stern, OvaScience
Moderator: Barry Greene, Alnylam

2:00-2:30 pm

Networking Break

2:30-3:00 pm

Impact of the Hot IPO Market on Deal-making
Ros Deegan
, Trevena; Tony Gibney, Leerink; Tom Leggett, UBS; Jeff Walsh, bluebird bio
Moderator: Bill Hicks, Mintz Levin

3:00-3:30 pm

The Deals of Tomorrow: Predictions and Wish Lists
Mike Handley, CHD Bioscience; Chris Haskell, Bayer; Brian McVeigh, GlaxoSmithKline; Geoff Meyerson, Locust Walk Partners; Bryan Stuart, Civitas Therapeutics
Moderator: Andrew Dickinson, Lazard

3:30-4:00 pm

Increased Competition in the Rare Diseases Space
Kees Been, Lysosomal Therapeutics; Steve Engen, Renegen; Barry Greene, Alnylam; JC Gutierrez-Ramos, Pfizer
Moderator: Ashley Dombkowski, Bay City Capital

4:00-4:30 pm

What's New in Cancer?
Steve Bloom, Ziopharm Oncology; Reid Leonard, Merck; Debanjan Ray, CytomX; Markus Warmuth, H3 Biomedicine
Moderator: Dan Paterson, Verastem

4:30-5:00 pm

Large Biopharma
Richard Brudnick, Biogen; Iain Dukes, Merck; Mark Miller, Eli Lilly; Praveen Tipirneni, Cubist
Moderator: John Maraganore, Alnylam

5:00-6:00 pm

Presentation of Deal of the Year Award and Cocktails
Nominees: Alnylam/Genzyme, Alnylam/MerckShire/ViroPharmaCubist/OptimerJ&J Innovation Centers

Co-hosts: PJ Anand, Brian Concannon, Michelle Dipp, Ashley Dombkowski, Iain Dukes, Chris Garabedian, Barry Greene, JC Gutierrez-Ramos, Tim Harris, Mary Lynne Hedley, John Maraganore, Mark Miller, Dan Paterson, Laurence Reid, Jason Rhodes, Rick Shea, Christoph Westphal

Sponsored by: